Trulieve Archives - Green Market Report

Adam JacksonSeptember 26, 2022
khalifakush-scaled.jpeg?fit=1200%2C1201&ssl=1

4min1830

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) will launch Khalifa Kush medical cannabis products in Florida this weekend — part of an exclusive partnership with multi-platinum selling artist Wiz Khalifa.

Patients can visit any Trulieve location in Florida on October 1 for a chance to receive Khalifa Kush swag and prizes.

“I’ve always been driven to create art and products that change people’s perceptions or offer different experiences, so to me Khalifa Kush is a big part of that,” said Wiz Khalifa. “Trulieve is the perfect partner for us because of its commitment to providing the highest quality products and best possible patient experiences.”

Trulieve said that Wiz Khalifa will personally meet with Trulieve patients at three South Florida dispensaries on Saturday, October 1:

  • 1:00 p.m. @ Coral Springs – 10404 W Atlantic Blvd.
  • 2:30 p.m. @ Hollywood – 2908 Hollywood Blvd.
  • 4:00 p.m. @ North Miami Beach – 15100 Biscayne Blvd.

Each of the three event locations will provide patients branded merchandise and will feature live DJs. Khalifa will also offer limited meet-and-greet opportunities for patients.

“Trulieve is honored to have the iconic Wiz Khalifa as an exclusive partner in Florida to curate and promote his unique product line,” said Kim Rivers, CEO of Trulieve. “As an artist, he has such a strong vision of how he wants to express himself.”

The company said that a select number of patients at the three locations that Khalifa visits will receive tickets to attend the Saturday-night Khalifa Kush afterparty at the popular E11even nightclub in downtown Miami.

Trulieve said that the Khalifa Kush product line will expand to all statewide locations in the coming months. Khalifa Kush products are already available in Trulieve-owned and operated locations in Arizona.

“Together, we’ve created a line of products that offer best-in-class cannabis to Florida patients and represent the passion and creativity that Wiz Khalifa is known for,” Rivers said.


Debra BorchardtAugust 10, 2022
Trulieve3.jpg?fit=960%2C720&ssl=1

5min190

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) delivered its results for the quarter ending June 30, 2022, with revenue increasing 49% year over year to $320.3 million from $215.1 million and 1% sequentially. This was in line with the Yahoo Finance average analyst estimates for revenues of $320 million.

Trulieve also reported a net loss of $22.5 million, a sequential improvement of 30%. The company said that the adjusted net loss of $1.1 million excludes $11.8 million of transaction, acquisition, integration, and other non-recurring charges primarily associated with the Harvest acquisition, a $5.2 million earnout payment for acquired cultivation in Arizona$4.3 million in asset impairments associated with the closing of redundant cultivation facilities in Florida and a loss of $0.7 million due to the repurposing of a development stage production site in Arizona.

Lowering Guidance

Disappointing investors, Trulieve decided to err on the cautious side when it came to its forecast. The company decided to cut its revenue guidance by 5% citing strategic changes across its businesses, the impact of inflation on consumer spending, softness in wholesale markets, and the lack of visibility in the current macroeconomic environment. The revenue is now expected to come in at the low end of its prior outlook from $1.25 billion to $1.3 billion. Trulieve also said it expects adjusted EBITDA will be in the range of $415 million to $450 million.

“Our team delivered strong second-quarter results with topline growth and margin improvement by staying focused on our plan,” said Kim Rivers, Trulieve CEO. “During our mid-year strategic review, we identified proactive measures to address the rapidly evolving economic landscape.”

Rivers continued, “We are committed to meeting customer needs, improving performance in core markets, managing cash wisely, and streamlining operations across the company. We strongly believe that taking firm and decisive action now will better position the organization to capitalize on numerous catalysts in the years ahead. Trulieve has the capital, discipline, and experience to navigate short-term headwinds and emerge as a stronger company.”

Changing Focus

Part of the moves that Trulieve is making within its huge portfolio of stores, is the exit from Nevada. The company is leaving the wholesale market there and said it is exploring a total escape from the state. The company said it has opened seven new dispensaries in Phoenix, ArizonaApopkaCoral SpringsHollywood, and Kissimmee, Florida; and Hurricane and Morgantown, West Virginia. The new Phoenix dispensary is the first branded Trulieve store in Arizona, kicking off statewide rebranding efforts to continue over the next year.

While the company did open one location during the quarter in Massachusetts and Pennsylvania, it has mostly been absent from the emerging Northeast market.


StaffJuly 20, 2022
daily_hit001.png?fit=1200%2C344&ssl=1

4min250

The Daily Hit is a recap of the top cannabis business stories for July 20, 2022.

ON THE SITE

Cannabis Tech Firm Alleaves Looks To Expand, Raises $40 Million

Seed-to-sale technology firm Alleaves said it raised $40 million in a Series A funding round to expedite a multi-state commercial rollout, led by investment group The Eleven Fund at a valuation of $240 million. The financing deal comes during a time when a lack of cash is forcing cannabis companies to find new and creative ways to raise capital. Read more here.

Dutchie Jumps Into Fintech With Dutchie Pay

Cannabis platform tech company Dutchie is jumping into the world of fintech with the launch of Dutchie Pay, a fully-integrated digital payment solution. Cannabis companies have faced huge challenges on the payment side of the business since the major banks and credit card companies refuse to work with cannabis. The product remains federally illegal and that is enough for these financial institutions to just say no. Read more here.

Pink Market Capital Gives Trulieve a Rich Target Price

Freelance cannabis research firm Pink Market Capital Research published Trulieve Cannabis Corp. – A Titan in the Making, which examined how Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) has managed to rake in more revenue during the past year than its competitors and is increasingly penetrating key emerging states despite falling margins in the U.S. cannabis sector. Read more here.

IN OTHER NEWS

Avicanna Inc., Ei.Ventures, Inc.

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announced that the company has entered into an intellectual property licensing & royalty agreement with Ei.Ventures, Inc. to develop and commercialize functional fungi-based products. Read more here.

Heritage Cannabis Holdings Corp.

Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) announced the launch of Heritage Helps, a new program embraced by management, employees and stakeholders that will be introduced throughout 2022. Heritage Helps is a multi-faceted program that combines initiatives that support the environment and communities in which it operates. Read more here.

Cova Software

Cova Software, a leading cannabis Point of Sale (POS) software company powering over 2,000 dispensaries across North America, announced the company will now support secure and convenient digital payment options, starting with debit card processing, for its U.S. dispensary customers through Cova Pay. Read more here.


Adam JacksonJuly 20, 2022
Trulieve3.jpg?fit=960%2C720&ssl=1

9min171

Freelance cannabis research firm Pink Market Capital Research published Trulieve Cannabis Corp. – A Titan in the Making, which examined how Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) has managed to rake in more revenue during the past year than its competitors and is increasingly penetrating key emerging states despite falling margins in the U.S. cannabis sector.

“The report on Trulieve is our first published report here at Pink Horse Capital Research, where we aim to publish our findings on small & mid-cap equities, the companies that most research firms don’t cover,” the report said. “Though we aim to be unbiased, please note that we do have a position in the company.”

 The report released on Sunday explored the company’s business model and growth strategies, its key financial metrics as well as the risks posed to both the company and the cannabis sector as a whole – subsequently assigning a fair value range for Trulieve of $79.30 – $96.92 per share. That’s a fairly lofty valuation as Trulieve shares were lately selling at approximately $12.70. 

Pink Market Capital gets to this number with a couple of big market assumptions. First, the analyst believes Trulieve’s home state of Florida could add adult-use sales in mid-2025, boosting revenue. They also think the company’s key state of Pennsylvania could go that route as well by 2025.  The report said, “This assumes a Nov ballot initiative in 2024 that would provide the framework for Trulieve to sell to adults over 21 in the state.” Then the report suggests that the company’s free cash flow would turn positive at a 10% yield to revenue beginning in 2025. The report went on to surmise that if Trulieve maintains a significant market share in its cornerstone hubs in 2026, that would lead to a 9.18% U.S. market share by 2030.

Thrive or Survive

Despite the slow crawl toward federal legalization, the global legal cannabis market size is expected to reach $134.4 billion by 2030, with a CAGR of 25.3% between this year and then, according to a new report by Grand View Research, Inc. The report partly credited the growth to the rising geriatric population and increasing demand for cannabis for various medical purposes, such as management of chronic pain, mental disorders, chemotherapy-induced nausea and neurological disorders.

 And while Florida’s medical marijuana market has been notoriously tough to enter for entrepreneurs, Trulieve performing well in the tax-friendly Sunshine State demonstrates opportunities for considerable growth. Those gaining sizable footprints in Florida’s emerging legal market more neatly position themselves for the implementation of recreational marijuana legalization.

 For Trulieve, this means focusing on growing within current markets – rather than land-grabbing throughout the country – and building upon their “Hub” model approach, which emphasizes establishing cost-effective scale in regional markets near “pillar” states tucked into the corners of the country such as Philadelphia, Florida, and Arizona. CEO Kim Rivers has hinted at the possibility of five hubs – setting the stage for effective interstate travel if approved by the federal government. Pink Market Capital Research expects Trulieve to enter more developed markets through M&A “when the company finds more attractive opportunities.” And until federal legislation is passed and implemented, navigating the patchwork of nascent markets will remain a challenge for even the largest players – especially as inflation and rising interest rates cool down activity. 

At the same time, the legal industry will continue to languish behind an expansive illicit market that has always been able to offer more competitive pricing and bypass state taxes, rules and regulations that have burdened smaller operators struggling to penetrate the world’s oldest legal marijuana market. California’s Democratic Gov. Gavin Newsom signed into law last month solutions meant to remedy the tax burden for many businesses in the state – eliminating a weight-based tax for cannabis growers but leaving the 15% tax on retail sales. The bill also allows the state to eventually raise retail taxes to make up for the lost cultivation revenue. Decelerating consumer growth in Western states such as California and Colorado “suggests that the most established markets are nearing saturation of consumer participation, which stands in sharp contrast to the rapid growth happening in new and emerging markets,” according to a report by Colorado-based cannabis data firm BDSA Analytics.

 “One market that deserves recognition is the massive Florida market, which saw its consumer participation rate jump from 24% in Spring 2020 to 49% in Spring 2022,” BSDA said.

 Maintain a Win Formula

 The report showed that Trulieve possesses a healthy balance sheet, “and there is minimal risk for the company to default on its debt or not pay its current obligations,” it said. “There is also ample cash to make opportunistic investments should the right circumstance arise.”

Risks that could limit potential growth for the company remain, it added. With nearly a couple hundred dispensaries, the retail-heavy company could more greatly feel the impact of federal legislation that restricts cannabis companies from being vertically integrated.

 And whether Trulieve can repeat its success in Florida across other states is yet to be seen. The decision to sit out on emerging Northeast markets such as New Jersey and New York may or may not mature in the company’s favor. New York has recently had issues trying to crack down on budding off-the-books pot shops in lieu of state legalization.

 “Time will tell if sitting out will hurt or help Trulieve in the long run,” the report said.


Debra BorchardtJuly 5, 2022
shutterstock_1720647154.jpg?fit=960%2C641&ssl=1

5min150

Cantor Fitzgerald analyst Pablo Zuanic issued a report this morning in which he sees some value in the beaten-up cannabis group, although he also cautioned that numerous roadblocks remain. He was clear that the group may not have even found a bottom yet as prices continue to slide along with the broader market. Zuanic also noted that even the second quarter might not bring relief on valuations, but he is a selective buyer at these levels. Having said that he said investors may not see any meaningful upside for another two to three years and that it would probably only occur when some sort of federal reform occurs.

Current Valuation

Zuanic wrote, “The MSOS ETF fell 25% in the last month vs. a 7% drop for the S&P500, and over the last three months it is down 49% vs. -15% for the SPX Index (yoy -75% vs. -12%). Even on risk-on days, when the larger Canadian LPs move up, MSOs either drop or stay flat. The MSO stock performance masks encouraging medium and long-term sales trends, with more states legalizing since 4/1 (NM, NJ), or soon to start rec sales (RI, CT/NY), or soon to vote to legalize (MD, MO); also, states like IL could see growth accelerate as more stores open, as we have recently seen in MI (+22% seq sales trends based on Apri/May data).”

If investors were hoping for some relief in the second quarter, then Zuanic dashed those hopes. He said that the second quarter boost will most likely only apply to those companies in New Jersey. Adult-use sales begin in the state on April 21 and sales have reportedly been very good. Plus, investors have been increasingly focused on profit margins and cash flows, which dampens buying. The companies with good cash flow are also beset with high taxes and debt levels are high.

“In this context, where it is difficult to call the bottom (as technicals and poor liquidity exacerbate stock swings and concerns about the lack of reform at the federal level and about state level fundamentals), we would tread carefully and are buyers only selectively of a few MSOs. We think the current state of affairs will lead to further consolidation (Columbia Care was at 0.9x debt to sales as 3/31/22, and we think that contributed to the decision to sell at the bottom) and benefit those in a stronger position,” wrote Zuanic.  He says he is focused on quality and his top picks (in alphabetical order) remain: Cresco (CRLBF. OW) proforma (1.7x C23 EV/Sales), Curaleaf (CURLF, OW) (2.7x), Green Thumb (GTBIF, OW) (1.6x), and Trulieve (TCNNF, OW) (1.9x).

Sales Trends

The analyst took a temperature read on sales in the second quarter based on data from Headset. He cautioned that it wasn’t official hard data, but did gather that second-quarter sales overall had improved from the first quarter. Most companies had reported that first-quarter sales dropped from the fourth quarter, so this improvement is welcome. However, early indications seem to say that sales dropped versus 2021 for the same time period. He believes these sales figures are competing with last year’s stimulus checks that consumers got during the pandemic.

Cannabis prices seem to be falling as much as the stock prices. The analyst cited Cannabis Benchmarks and pointed out that wholesale prices nationwide (in the 18 states it tracks) averaged $1,057/lb for the week ending 7/1, down 16% from 4/1/22 and down 20% YTD (-35% you). “Regarding key MSO states that we track: AZ -9% seq and -45% YTD; CA -4% and -20%; CO -9% and -17%; CT -10% and -9%; IL +1% and -12%; MA -7% and -37%; MI +4% and -43%; NV -5% and -14%. We realize lower wholesale prices sometimes may be neutral for companies just focused on retail, but most of the MSOs that we track have cultivation and tend to be vertically integrated,” he wrote.

 

 


Debra BorchardtMay 26, 2022
stockmarket.jpg?fit=960%2C576&ssl=1

3min190

As the cannabis industry matures, certain patterns are beginning to be established not unlike other retail industries. The one that just occurred is the first-quarter dip in sales. As companies are delivering their first-quarter results, many told investors that sales dipped after the fourth quarter, but that the second quarter was picking up.

Especially companies that have the early jump on New Jersey adult-use sales. These companies have gotten a taste of the impact these sales will have on their companies. They have a pretty good idea that the next few quarters are going to kick butt.

Stock prices for cannabis companies have been pummeled over the last year. Frustrated executives have complained about posting mostly rising revenues only to see the stocks sell-off. Expectations for a strong back half of the year and excessive valuation devastation are combining to create a perfect buying opportunity and these executives are letting their purchases do the talking.

Buying

Trulieve

Led by CEO Kim Rivers, a slew of Trulieve executives have bought stock lately. Here’s the rundown:

Executive                       Shares Bought

CEO Kim Rivers             14,000

President Steve White   7,000

CFO Alex D’Amico          1,500

CPO Kyle Landrum         1,250

CSO Tim Morey                700

CLO Eric Powers              1,700

CTO Nilyum Jhala            1,000

CIO Jason Pernell             3,500

IR Christine Hersey          1,000

Columbia Care

CEO Nicholas Vita                    25,000

TerrAscend

Chair Jason Wild               18,000

Curaleaf

Chair Boris Jordan             566,000 (converted or exchanged)

Selling

Despite the potential improvement in stock prices some companies have seen insider selling. Here are some of the big sellers:

Planet 13

East Coast Pres. Michael Jennings       137,400

Ascend Wellness

HR Robin Debiase                                     15,000

 

In Closing

Many traders believe that insider buying is a signal of a market bottom. These individuals are often considered to be smart money. Vickers Insider Weekly wrote in a note published on Monday, “Corporate insiders have reacted with increasing optimism, expressing confidence that historically has come in advance of notable rallies.”


Debra BorchardtMay 12, 2022
Trulieve3.jpg?fit=960%2C720&ssl=1

5min230

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced its results for the first quarter ending March 31, 2022, with revenue increasing 64% year over year to $318.3 million from $193.8 million and 4% sequentially. This beat the Yahoo Finance average analyst estimates for revenues of $307 million. It was also a nice increase sequentially from the fourth quarter’s revenue of $305 million, especially at a time when many cannabis companies have seen sales in the first quarter of 2022 struggle to top the fourth.

Trulieve also delivered a net loss of $32 million, a sequential improvement of 55%, however, it was a big change from last year’s net income of $30 million for the same time period. The earnings per share were ($0.17) versus last year’s $0.24. This missed the average analyst estimates for earnings of $0.03.

The company also noted that it had an adjusted net income of $1.7 million, which excludes $17.2 million of transaction, acquisition, integration, and other non-recurring charges primarily associated with the Harvest acquisition, $13.8 million in asset impairments associated with the closing of redundant cultivation facilities and a loss of $2.7 million due to the divestiture of a duplicative, non-operating location.

“Thanks to the efforts of all of our Trulieve employees, we’re off to a great start in 2022, with strong first-quarter results underpinned by topline growth and cash flow,” said Kim Rivers, Trulieve CEO. “We delivered another record quarter while making substantive progress on our plan to optimize assets while preparing for future growth and catalysts. In 2022 we expect our strong balance sheet, access to capital and financial discipline will uniquely position us to capitalize on market opportunities created by the macroeconomic factors impacting our industry.”

Operating expenses did shoot up 138% to $149 million

Financial Guidance

Trulieve is reiterating its 2022 guidance with expected revenue in the range of $1.3 billion to $1.4 billion and adjusted EBITDA in the range of $450 million to $500 million. Based on the company’s current forecasts, it expects to realize improved performance in the second half of 2022 relative to the first half of 2022.

The company is also sitting comfortably on a mountain of cash at the quarter end of $267 million, bolstered by $45.1 million in cash flow from operations and the closing of $75 million senior secured notes at 8% due October 2026.

Trulieve currently operates 165 retail dispensaries and over 4.0 million square feet of cultivation and processing capacity in the United States.


StaffMay 4, 2022
shutterstock_1855501255.jpg?fit=960%2C720&ssl=1

3min230

On April, 28, 2022, Green Market Report held its first-ever Women’s Summit. During the event, the Women’s Leadership Awards were announced and presented to the winners. Over the next two weeks, we will highlight each of these winners and congratulate them on their contributions to the cannabis industry.

Women’s Leadership Award

C-Suite Public Company

Kim Rivers

 

Kim Rivers is CEO of Trulieve Cannabis Corp. (OTC: TCNNF), a vertically-integrated “seed-to-sale” operation based in Florida. Rivers joined Trulieve at its inception and has been the key driver for the company’s customer-centric vision, strong growth, strategic expansion and industry-leading profitability. Ms. Rivers oversees every activity involved with the cannabis process to ensure quality, operational integrity and financial success. She is the only female CEO of a publicly-traded MSO in the cannabis space.

 

Prior to Trulieve, Ms. Rivers spent several years in private practice as a lawyer where she specialized in mergers, acquisitions and securities for multi-million dollar companies and has run a number of successful businesses from real estate to finance. Her experience has been instrumental in building Trulieve’s market-leading position in its home state of Florida and provides the solid foundation to execute growth and expansion initiatives as an MSO.

 

Last year, Kim spearheaded the largest cannabis acquisition deal to date. Trulieve’s purchase of Harvest Health & Recreation created the largest cannabis company in the U.S. The deal was signed within a record 5 months.

 

Under Kim’s guidance, Trulieve released the first Environmental, Social, and Governance (ESG) report from an American MSO. Rivers said the impetus behind the report was to ensure the cannabis industry is safe, inclusive, equitable and sustainable for generations to come – and that the company has a commitment to operating transparently for its stakeholders and the industry at large. 

 

Ms. Rivers plays an active role in her community and serves on numerous charitable boards.

 


Julie AitchesonApril 28, 2022
shutterstock_1855501255.jpg?fit=960%2C720&ssl=1

8min451

On Thursday, April 26th, the first-ever Green Market Report Women’s Leadership Awards ceremony was held at The Green Market Report Women’s Summit in Manhattan, NYC to honor female and female-identifying cannabis professionals in categories ranging from Cultivation to Activism and Politics. 

The Women’s Leadership Award in the Brands category went to Nancy Whiteman, CEO of Wana Brands. Honored for her adroit management of Canadian cannabis company Canopy Growth’s acquisition of 100% of each Wana entity as well as her commitment to social equity in cannabis, Whiteman was also lauded for her innovative new product lines and product development. Khadijah Tribble, Vice President of Corporate Responsibility at Curaleaf, (OTC: CURLF) received the Women’s Leadership Award in the MSO category. A highly-respected expert on equity and inclusion in cannabis, Tribble created and runs Rooted in Good, one of the most robust corporate responsibility programs in any industry, and is also the founder of Marijuana Matters, a cannabis education and advocacy incubator. 

The Women’s Leadership Award in Marketing went to Natalie Shaul, Co-Founder and VP of Marketing at Springbig. Shaul was instrumental in Springbig’s pivot to cannabis and is known as a trendsetter, job creator, fundraiser and changemaker in the industry. Shaul has helped thousands of cannabis retailers while her business has created more than 80 jobs across South Florida while providing discounted services to support veteran and minority-owned cannabis businesses.

Kim Rivers, CEO of Trulieve Cannabis Corp., was given the Women’s Leadership Award in the C-Suite- Public Company category. She is the only female CEO of a publicly traded company in the cannabis space. A former lawyer, Rivers has since spearheaded the largest cannabis acquisition deal to date with Trulieve’s purchase of Harvest Health & Recreation. Rivers was also instrumental in Trulieve’s Environmental, Social and Governance report, the first of its kind from an American MSO. The award for Women’s Leadership in the C-Suite Private Company category went to Ralina Shaw, founder of House of Tyne and leadership team member of 4thMVMT, a leading social impact organization with a mission to support those disproportionally impacted by cannabis laws. She is also one of the few BIPOC executives in the PR and Retail space.

Founder and CEO of Women Employed in Cannabis (WEIC) Kyra Reed was given the Women’s Leadership Award in Activism/Politics for her helming of the largest association for women working in cannabis, psychedelics, hemp & CBD. Named as a “Social Media Pioneer” by Entrepreneur Magazine, Reed has grown WEIC into a 15,000 member organization as well as the premiere brand and international organization dedicated to empowering women to achieve their goals.

The Women’s Leader Award for Cultivation went to Joyce Cenali, COO of Sonoma Hills Farm. Under Cenali’s leadership, Sonoma Hills was the first farm to be recognized as “organic comparable” as designated by CCOF’s OCal program. She co-founded an Emerald Cup-winning organization and supports female founders innovating in cannabis with a mission to advance a regulatory model that unites capitalism and inclusion. Chanda Macias, PhD, CEO of Ilera Holistics, took home the award for Women’s Leadership in the Science category, in no small part for her role as the first Black woman medical cannabis operator as CEO of National Holistic Healing Center—the largest medical marijuana dispensary in Washington, D.C.  She is also Chairwoman of the Board of Managers and CEO for Women Grow and First Vice Chair of the National Cannabis Roundtable Board.

Narmin Jarrous, Chief Development Officer at Exclusive Brands, won the Women’s Leadership Award in Social Equity. Jarrous’s social equity program partners with organizations like the National Birth Equity Coalition and The Last Prisoner Project while also helping Social Equity Applicants gain their licenses. Jarrous is also a mentor, educator, speaker, and advocate for women of color in the industry. Ronit Pinto, founder of Honeysuckle Magazine, took home the Women’s Leadership Award in Media. Honeysuckle has gained national distribution and also created Honey Pot Magazine, a sister print and digital publication focusing exclusively on cannabis and hemp issues.

Wendy Bronfein, Co-founder, Chief brand Officer and Director of Public Policy at Curio Wellness was honored in the Dispensary category. Bronfein drives the company’s legislative agenda across multiple states and oversees the brand as well as all corporate communications. She also helped initiate Curio’s Wellness investment Fund and a program to provide start-up capital for minority business-owners to open their own Curio franchise locations. The Women’s Leader Award for Public Relations went to Shawna Seldon McGregor, founder and CEO of Maverick Public Relations. She represents businesses across all sectors and is recognized as one of the most effective cannabis agencies in the industry. MacGregor has provided pro bono PR work and has served on the boards of numerous charitable organizations.

Honorees were nominated by colleagues from across cannabis sectors. Almost a hundred nominations were reviewed by industry insiders before they decided upon the twelve women executives and entrepreneurs to receive these special awards spanning several areas within the cannabis industry. 

 


Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 7 hours

Landlords Just Saying No To Cannabis

@GreenMarketRpt – 13 hours

Cannabis Banking Bill Passage After Election Season Is ‘Likely’, Analyst Says

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.